October 15, 2013
The Ministry of Health, Labor and Welfare’s (MHLW) Diovan investigation committee formally compiled on October 8 its interim report. It remains unclear who manipulated data on the angiotensin receptor blocker (ARB) Diovan (valsartan) studies and for what reason, and a...read more